Acid-PEG5-t-butyl ester: Handling & Application Guidelines

Acid-PEG5-t-butyl ester is a heterobifunctional polyethylene glycol derivative bearing a free carboxylic acid at one terminus and a protected t-butyl ester at the other, making it a versatile orthogonal linker for bioconjugation, PROTAC assembly, and drug-delivery scaffold construction.

Product SKU

A596986

Chemical Class

Heterobifunctional PEG linker

Reactive Groups

Carboxylic acid (free) and t-butyl ester (protected carboxylic acid)

PEG Chain Length

5 ethylene oxide units (PEG5)

Key Application

PROTAC linker synthesis, bioconjugation, drug-delivery scaffolds

Orthogonal Chemistry

Free acid can be activated independently; t-butyl ester deprotected with TFA

Chemical Properties and Structure

Acid-PEG5-t-butyl ester (SKU: A596986) is a linear, heterobifunctional PEG reagent consisting of five ethylene oxide repeating units flanked by two chemically distinct termini. One end presents a free carboxylic acid (–COOH), which can be directly engaged in amide-bond formation via standard carbodiimide (EDC/NHS) or active-ester coupling chemistry. The opposing terminus carries a t-butyl ester, a mild acid-labile protecting group that masks a second carboxylic acid functionality.

The PEG5 spacer confers water solubility, conformational flexibility, and reduced immunogenicity to conjugated molecules, properties well established for PEG-based linkers in the literature. The orthogonal reactivity of the two termini allows sequential, chemoselective modification strategies without the need for global protecting-group manipulations.

Storage and Handling Guidelines

Storage: Store Acid-PEG5-t-butyl ester at –20 °C in a tightly sealed container, protected from light and moisture. PEG-based reagents are hygroscopic; prolonged exposure to ambient humidity can cause hydrolysis of the t-butyl ester or reduce coupling efficiency of the free acid. Allow the vial to equilibrate to room temperature before opening to prevent condensation.

Reconstitution: Dissolve the compound in anhydrous dimethyl sulfoxide (DMSO), dimethylformamide (DMF), or dichloromethane (DCM) immediately before use. Aqueous solutions should be prepared only when required for conjugation reactions and used promptly. Avoid repeated freeze-thaw cycles; prepare single-use aliquots in inert amber vials when possible.

Safety: Handle in a well-ventilated fume hood using standard personal protective equipment (lab coat, nitrile gloves, safety glasses). Consult the Safety Data Sheet (SDS) provided by Aladdin Scientific before use. Dispose of waste solvents and reagent residues in accordance with local institutional and regulatory requirements.

Step-by-Step Protocol for Bioconjugation Using the Free Acid Terminus

The following protocol outlines EDC/NHS-mediated amide-bond formation between the free carboxylic acid of Acid-PEG5-t-butyl ester and a primary amine-bearing biomolecule (e.g., lysine residue on a protein or an amine-functionalized small molecule).

1. Prepare stock solutions: Dissolve Acid-PEG5-t-butyl ester in anhydrous DMSO to a concentration of 10–50 mM. Prepare EDC·HCl and NHS (or sulfo-NHS for aqueous compatibility) as fresh solutions in 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 5.5–6.0.
2. Activate the carboxylic acid: Combine the linker with EDC (2–5 molar equivalents) and NHS (2–5 molar equivalents) in MES buffer. Incubate for 15–30 minutes at room temperature with gentle mixing. This generates an NHS ester intermediate.
3. Couple to the amine-containing molecule: Adjust the pH to 7.2–7.5 using phosphate-buffered saline (PBS). Add the amine-bearing biomolecule (1–1.5 molar equivalents relative to activated linker) and react for 2 hours at room temperature or overnight at 4 °C.
4. Purify the conjugate: Remove unreacted reagents by size-exclusion chromatography (SEC), dialysis, or spin-filtration appropriate to the molecular weight of the conjugate.
5. Deprotect when required: To expose the second carboxylic acid from the t-butyl ester, treat the purified conjugate with 20–50% trifluoroacetic acid (TFA) in DCM for 1–2 hours at room temperature, then evaporate solvent under a nitrogen stream. Verify deprotection by LC-MS or NMR.

Note: Optimize reagent ratios, reaction time, and pH empirically for each specific substrate. The DMSO co-solvent should not exceed 10% v/v in aqueous coupling steps to maintain protein stability.

Applications in PROTAC and Drug-Delivery Research

PROTAC Linker Synthesis: Proteolysis-targeting chimeras (PROTACs) are bifunctional molecules that recruit an E3 ubiquitin ligase to a target protein of interest, directing it for proteasomal degradation. PEG-based linkers such as Acid-PEG5-t-butyl ester are widely employed in PROTAC design because the hydrophilic PEG chain improves aqueous solubility, cell permeability, and conformational accessibility of the ternary complex. The orthogonal functional groups enable sequential conjugation: the free acid can be coupled to one pharmacophore while the t-butyl ester is deprotected at a later synthetic step to provide a handle for coupling the second pharmacophore.

Drug-Delivery Scaffolds and ADCs: In antibody-drug conjugate (ADC) and nanoparticle drug-delivery research, PEG5 spacers reduce steric hindrance, improve linker hydrophilicity, and can modulate payload release kinetics. Acid-PEG5-t-butyl ester provides a convenient synthetic intermediate for building pH-sensitive or enzymatically cleavable constructs when combined with appropriate cleavable motifs.

Surface Functionalization: The compound can also be used to PEGylate amine-functionalized surfaces (nanoparticles, beads, biosensor chips) via EDC/NHS chemistry at the carboxylic acid end, while the protected ester terminus is retained for subsequent attachment of targeting ligands after deprotection.

Frequently asked questions

What solvents are recommended for dissolving Acid-PEG5-t-butyl ester?

Anhydrous DMSO, DMF, and DCM are the preferred solvents for preparing stock solutions of Acid-PEG5-t-butyl ester, as they minimize premature hydrolysis of the t-butyl ester or the activated carboxylic acid intermediate. Aqueous solutions should be prepared freshly and used immediately; avoid prolonged storage in water.

How is the t-butyl ester protecting group removed?

The t-butyl ester is selectively deprotected under mild acidic conditions, most commonly by treatment with 20–50% trifluoroacetic acid (TFA) in dichloromethane (DCM) at room temperature for 1–2 hours. After reaction, the volatile reagents are removed under a nitrogen stream or vacuum, revealing the free carboxylic acid. Confirm complete deprotection by LC-MS or NMR analysis.

Why is Acid-PEG5-t-butyl ester useful for PROTAC synthesis?

This compound offers two orthogonal carboxylic acid handles—one immediately available and one protected—enabling sequential, chemoselective attachment of two different pharmacophores (e.g., a target-binding ligand and an E3 ligase recruiter) without cross-reactivity. The PEG5 chain simultaneously improves aqueous solubility and molecular flexibility, both of which are critical for efficient ternary complex formation in PROTAC-mediated target degradation.

What is the recommended storage temperature and shelf life?

Acid-PEG5-t-butyl ester should be stored at –20 °C in a sealed, moisture-free container away from light. Under these conditions, the reagent is expected to remain stable for an extended period; however, users should verify lot-specific expiry information on the product label or certificate of analysis. Avoid repeated freeze-thaw cycles by preparing single-use aliquots.

Can Acid-PEG5-t-butyl ester be used in aqueous bioconjugation reactions directly?

Yes, the compound can participate in aqueous EDC/NHS-mediated coupling reactions through its free carboxylic acid terminus. However, stock solutions should be prepared in an organic solvent (e.g., DMSO) and diluted into aqueous buffer immediately before use, keeping the organic co-solvent below 10% v/v. Prolonged incubation in aqueous conditions at elevated temperature should be avoided to prevent unintended hydrolysis of the t-butyl ester.

References

1. Bunnage, M. E. et al. Know your target, know your molecule. Nature Chemical Biology, 2015. General reference on rational linker design in drug discovery.
2. Bai, N. et al. Rationalizing PROTAC-mediated ternary complex formation using Rosetta and binding free energy calculations. Journal of Chemical Information and Modeling, 2021. Discusses PEG linker role in PROTAC ternary complexes.
3. Hermanson, G. T. Bioconjugate Techniques, 3rd Edition. Academic Press, 2013. Standard reference for EDC/NHS carbodiimide coupling protocols.
4. BroadPharm product reference: BP-20439, Acid-PEG5-t-butyl ester. https://broadpharm.com

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.